Clindamycin

Clindamycin Struktur
18323-44-9
CAS-Nr.
18323-44-9
Bezeichnung:
Clindamycin
Englisch Name:
Clindamycin
Synonyma:
clindamycine;CLDM;7-cdl;U-21251;sobelin;dalacinc;clinimycin;CLINDAMYCIN;chlolincocin;Clindamycin Base
CBNumber:
CB4399999
Summenformel:
C18H33ClN2O5S
Molgewicht:
424.98
MOL-Datei:
18323-44-9.mol

Clindamycin Eigenschaften

alpha 
D +214° (chloroform)
Siedepunkt:
134°C (rough estimate)
Dichte
1.1184 (rough estimate)
Brechungsindex
1.6100 (estimate)
storage temp. 
Store at -20°C
Löslichkeit
DMSO:52.5(Max Conc. mg/mL);123.54(Max Conc. mM)
DMF:30.0(Max Conc. mg/mL);70.59(Max Conc. mM)
Ethanol:52.5(Max Conc. mg/mL);123.54(Max Conc. mM)
PBS (pH 7.2):0.2(Max Conc. mg/mL);0.47(Max Conc. mM)
Aggregatzustand
A crystalline solid
pka
7.6(at 25℃)
BCS Class
1
Stabilität:
Hygroscopic
CAS Datenbank
18323-44-9(CAS DataBase Reference)
EPA chemische Informationen
L-threo-?-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio- (18323-44-9)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Giftige Stoffe Daten 18323-44-9(Hazardous Substances Data)
Toxizität LD50 subcutaneous in rat: 2618mg/kg
Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P280, P305+P351+P338,P337+P313P
H362 Kann Säuglinge über die Muttermilch schädigen. Reproductive toxicity, effects on or via lactation Additional category P201, P260, P263, P264, P270,P308+P313
Sicherheit
P201 Vor Gebrauch besondere Anweisungen einholen.
P260 Dampf/Aerosol/Nebel nicht einatmen.
P263 Kontakt während der Schwangerschaft /und der Stillzeit vermeiden.
P264 Nach Gebrauch gründlich waschen.
P264 Nach Gebrauch gründlich waschen.
P270 Bei Gebrauch nicht essen, trinken oder rauchen.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P305+P351+P338 BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.
P308+P313 BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

Clindamycin Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Clindamycin, a derivative of lincomycin, was first isolated from Streptomyces lincolnesis in 1962 and became commercially available in 1966. The name originates from Lincoln, Nebraska, where the organism was first isolated from a soil sample. The parent compound of clindamycin is lincomycin, which is produced by actinomycete, Streptomyces liconelnensis, which belongs to the order of Actinobacteria. It replaced lincomycin use because of its better absorption and clinical spectrum. Lincomycin belongs to the lincosamides, which is a class of antibiotics. The compounds use as antibiotic agents stems from their ability to interfere with the protein synthesis of bacteria. The chemical modification of lincomycin, clindamycin, has proven to be superior to the natural product for clinical applications. Clindamycin is better absorbed from the gastrointestinal tract and food does not interfere with its absorption. It is also eight times more active against aerobic gram-positive cocci, and it has proven activity against gram-positive and gram-negative anaerobic bacteria as well as protozoal organisms like Toxoplasma and Plasmodium species.

Verwenden

Clindamycin is a semi-synthetic analogue of lincomycin, prepared by chloride substitution of the exocyclic sugar hydroxy group. This affords a more hydrophobic compound with improved pharmacodynamics. Like other members of the lincosamide family, clindamycin is a broad spectrum antibiotic with activity against anaerobic bacteria and protozoans. Clindamycin acts by binding to the 23S ribosomal subunit, blocking protein synthesis. Clindamycin has been extensively studied with over 8,000 literature citations.

Definition

ChEBI: Clindamycin is a carbohydrate-containing antibiotic that is the semisynthetic derivative of lincomycin, a natural antibiotic. The physiologic effect of clindamycin is by means of Decreased Sebaceous Gland Activity, and Neuromuscular Blockade.

Indications

Clindamycin (Cleocin), 300 to 450 mg/day, is an extremely effective agent for acne.

Kontakt-Allergie

This lincosanide antibiotic is used in topical form for acne, or systemically has been responsible for exanthematous rashes and acute generalized exanthematous pustulosis.

Mechanism of action

Clindamycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. The use of clindamycin with macrolides is not recommended since both of them compete for binding sites to the 50S subunit.

Clinical Use

Clindamycin is effective in the treatment of most infections secondary to anaerobes and gram-positive cocci. It can be used for anaerobic pulmonary, intra-abdominal, gynecologic, pelvic, diabetic foot, and decubitus ulcer infections. Another appropriate agent should be added since the majority of these infections are polymicrobial. It can also be used as an alternative agent for patients with severe penicillin allergy. It is also used to treat Clostridium perfringens infection.
Oral preparations of clindamycin and vaginal cream are alternatives to metronidazole for the treatment of bacterial vaginosis. Topical solution is used for treatment of acne vulgaris and rosacea.
Clindamycin is extensively metabolized by the liver and the half-life is prolonged in patients with cirrhosis and hepatitis. Dose reductions are recommended in patients with acute liver disease.

Nebenwirkungen

The most commonly observed adverse effect is diarrhea. The reported incidence of C. difficile colitis in patients treated with clindamycin varies from 0.1 to 10%. The syndrome may be fatal. If the patient develops C. difficile colitis, clindamycin should be discontinued and the patient should be treated for C. difficile . Other side effects include rash, nausea, vomiting, diarrhea, flatulence, abdominal distension, anorexia, and transient elevation of liver enzymes. Other less common events, such as fever, neutropenia, thrombocytopenia, and eosinophilia have been reported.

Clindamycin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Clindamycin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 199)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21695 55
SHANDONG ZHI SHANG CHEMICAL CO.LTD
+86 18953170293
sales@sdzschem.com China 2931 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 47465 58
career henan chemical co
+86-0371-86658258 15093356674;
factory@coreychem.com China 29826 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-81138252 +86-18789408387
1057@dideu.com China 3783 58
Hefei TNJ Chemical Industry Co.,Ltd.
0551-65418671
sales@tnjchem.com China 34572 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6313 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-89586680 +86-18192503167
1026@dideu.com China 9553 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 29474 58

18323-44-9(Clindamycin)Verwandte Suche:


  • Clindamycin (base and/or unspecified salts)
  • (2S,4R)-N-[(1S,2S)-2-Chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
  • CLDM
  • Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S)-1-methyl-4β-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside
  • Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside
  • U-21251
  • Clindamycin Base
  • 7-Chloro-7-deoxylincoMycin, 7-ChlorolincoMycin
  • L-threo-a-D-galacto-Octopyranoside, Methyl7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-Methyl-4-propyl-2-pyrrolidinyl]carbonyl]aMino]-1-thio-
  • L-threo-α-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-
  • methyl 7-chloro-6,7,8-trideoxy-6-({[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl}amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside
  • Clindamycin (free base)
  • CLINDAMYCIN
  • -1-thio-trans-alpha-l-threo-d-galacto-octopyranoside
  • 7-cdl
  • 7-chloro-7-deoxylincomycin
  • 7-chlorodeoxylincomycin
  • 7-chlorolincomycin
  • 7-deoxy-7(s)-chlorolincomycin
  • chlolincocin
  • clinimycin
  • clinimycin(rescinded)
  • dalacinc
  • methyl7-chloro-6,7,8-trideoxy-6-(1-methyl-4-l-threo-d-galacto-octopyranosid
  • methyl7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-l-2-pyrrolidinecarboxamido)
  • sobelin
  • trans-alpha-propyl-l-2-pyrrolidinecarboxamido)-1-thio
  • L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(2S,4R)-1-methyl-4-propyl-2-pyrrolidinylcarbonylamino-1-thio-
  • CLINDAMYCIN-HYDROCHLORIDE-ETHANOL(INTERMEDIATE)
  • Clindamycin - Dalacine | U 21251
  • Clindamycin Solution, 1000ppm
  • Clindamycin Solution, 100ppm
  • Clindamycin USP/EP/BP
  • ClindamycinQ: What is Clindamycin Q: What is the CAS Number of Clindamycin Q: What is the storage condition of Clindamycin
  • clindamycine
  • methyl7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]carbonyl]amino]-4-O-phosphono-1-thio-L-threo-α-d-galacto-octopyranoside(clindamycin4-phosphate)
  • (2S,4R)-N-((1S,2S)-2-Chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide
  • 18323-44-9
  • 21463-39-5
  • C18H33ClN2O5S
  • Inhibitors
Copyright 2019 © ChemicalBook. All rights reserved